Matches in Wikidata for { <http://www.wikidata.org/entity/Q37427287> ?p ?o ?g. }
- Q37427287 description "article científic" @default.
- Q37427287 description "article scientifique" @default.
- Q37427287 description "articolo scientifico" @default.
- Q37427287 description "artigo científico" @default.
- Q37427287 description "artículu científicu espublizáu en 2016" @default.
- Q37427287 description "bilimsel makale" @default.
- Q37427287 description "scientific article published on 06 September 2016" @default.
- Q37427287 description "vedecký článok" @default.
- Q37427287 description "vetenskaplig artikel" @default.
- Q37427287 description "videnskabelig artikel" @default.
- Q37427287 description "vědecký článek" @default.
- Q37427287 description "wetenschappelijk artikel" @default.
- Q37427287 description "wissenschaftlicher Artikel" @default.
- Q37427287 description "наукова стаття, опублікована у вересні 2016" @default.
- Q37427287 description "научни чланак" @default.
- Q37427287 description "مقالة علمية نشرت في 06 سبتمبر 2016" @default.
- Q37427287 name "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 name "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 name "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 type Item @default.
- Q37427287 label "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 label "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 label "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 prefLabel "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 prefLabel "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 prefLabel "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 P1433 Q37427287-AB118187-0BBA-4B72-852F-3049A4A8811E @default.
- Q37427287 P1476 Q37427287-BE888CD1-B5C5-4A21-B7E2-FEF3C26AE1B2 @default.
- Q37427287 P2093 Q37427287-20F21A91-63D8-4ED2-B7BC-7329E806921D @default.
- Q37427287 P2093 Q37427287-2A5CCD03-F02F-4FE3-A48E-8FDCC0A09F25 @default.
- Q37427287 P2093 Q37427287-A156A516-EB0D-41F3-A947-C84EBDCE3A96 @default.
- Q37427287 P2093 Q37427287-F5C0AFEF-15E6-4882-9116-2D545D658C4B @default.
- Q37427287 P275 Q37427287-7f6abd9c-58c2-497f-b482-0976e1021117 @default.
- Q37427287 P2860 Q37427287-0BFE3738-5A62-444B-9DBF-837937686339 @default.
- Q37427287 P2860 Q37427287-296FAEE8-8B30-442A-9D45-F9185C3E7D96 @default.
- Q37427287 P2860 Q37427287-2ACA9E55-8C43-4CD3-AF26-7952FA7D03C3 @default.
- Q37427287 P2860 Q37427287-354D6390-104E-4F66-B6A6-130206FAD67C @default.
- Q37427287 P2860 Q37427287-6A34DBED-7159-46C5-BAA7-72274CF1591F @default.
- Q37427287 P2860 Q37427287-6B9255DE-6A70-47F1-ABFA-D14C06E57C2B @default.
- Q37427287 P2860 Q37427287-7AEFC3C5-77D7-4C2F-BF4C-803AC0D9BBD9 @default.
- Q37427287 P2860 Q37427287-7D1C0B61-2019-46FD-B176-98A5E7205536 @default.
- Q37427287 P2860 Q37427287-85FDEC71-7C9D-47C5-9A72-1E2587DBF8A8 @default.
- Q37427287 P2860 Q37427287-88F6D42D-97E5-4748-9668-4D6A4B4ADBDB @default.
- Q37427287 P2860 Q37427287-8EFC76E7-0AF5-4237-8E7C-25BAC88DA191 @default.
- Q37427287 P2860 Q37427287-A07BEB9F-871B-4AF0-8E68-2D4A9BEF775B @default.
- Q37427287 P2860 Q37427287-AB80D8DF-4976-4A25-90DA-A0AC52A1C50C @default.
- Q37427287 P2860 Q37427287-B3A3116C-7C09-48B5-BF03-7831E8FFC039 @default.
- Q37427287 P2860 Q37427287-B750A30F-D1DA-48EC-B1DF-574921BE3770 @default.
- Q37427287 P2860 Q37427287-BF024032-2480-4BA9-A5FF-4EC5166A331F @default.
- Q37427287 P2860 Q37427287-C3DAF22D-BDAE-43CB-AE02-AB3688388978 @default.
- Q37427287 P2860 Q37427287-DBB587EB-DD08-45FF-93E2-C451D84705A6 @default.
- Q37427287 P2860 Q37427287-EB63DEA1-B259-467A-B46E-C7CDF320FC06 @default.
- Q37427287 P2860 Q37427287-F27946FF-4079-4643-AD44-C0A3FCD9741B @default.
- Q37427287 P2860 Q37427287-F8A809D6-15C6-4624-9521-F967CC8DB089 @default.
- Q37427287 P2860 Q37427287-FBB46201-8828-46CF-A710-ED3927BEFD1C @default.
- Q37427287 P2888 Q37427287-A5A768C7-5ECA-4722-9D74-727BF0E0097C @default.
- Q37427287 P304 Q37427287-6236147E-C48C-417B-B4E8-7AF5077FA163 @default.
- Q37427287 P31 Q37427287-48391A59-2811-4BCD-873B-56328B239505 @default.
- Q37427287 P356 Q37427287-B286D655-BA3C-484D-9187-EA0C329DEA11 @default.
- Q37427287 P433 Q37427287-795E081E-8FAD-42D1-993B-C2EBD1DF726E @default.
- Q37427287 P478 Q37427287-F163E220-62DE-4D5B-83F3-934096CAFFB2 @default.
- Q37427287 P50 Q37427287-B764F40D-E0F4-42E2-A359-59BF240B0010 @default.
- Q37427287 P577 Q37427287-208E1032-F35C-4783-B9E7-64CF801F0B26 @default.
- Q37427287 P6216 Q37427287-7af20437-ceda-440d-a729-d6ec7e73dd1b @default.
- Q37427287 P698 Q37427287-3233FBEB-D8AF-4C90-A04D-2C90734205C3 @default.
- Q37427287 P921 Q37427287-383BBF91-6D8A-483C-9010-326D423621F1 @default.
- Q37427287 P921 Q37427287-9E64B9DF-440D-4A49-9A7C-6CF8EE30E0B4 @default.
- Q37427287 P921 Q37427287-C664CC94-D371-458D-A86F-8A73E528F5FE @default.
- Q37427287 P932 Q37427287-3BF07410-9A4C-46D6-A856-BB6763C322C6 @default.
- Q37427287 P356 S13300-016-0196-5 @default.
- Q37427287 P698 27600385 @default.
- Q37427287 P1433 Q26853803 @default.
- Q37427287 P1476 "Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years" @default.
- Q37427287 P2093 "Abdullah Bereket" @default.
- Q37427287 P2093 "Line Conradsen Hiort" @default.
- Q37427287 P2093 "Lisbeth Bjerring Jensen" @default.
- Q37427287 P2093 "Valentina Peterkova" @default.
- Q37427287 P275 Q20007257 @default.
- Q37427287 P2860 Q28244983 @default.
- Q37427287 P2860 Q28288044 @default.
- Q37427287 P2860 Q30445990 @default.
- Q37427287 P2860 Q36533328 @default.
- Q37427287 P2860 Q36575356 @default.
- Q37427287 P2860 Q36629167 @default.
- Q37427287 P2860 Q36704848 @default.
- Q37427287 P2860 Q37977223 @default.
- Q37427287 P2860 Q40293055 @default.
- Q37427287 P2860 Q40810355 @default.
- Q37427287 P2860 Q44802256 @default.
- Q37427287 P2860 Q44953752 @default.
- Q37427287 P2860 Q45208962 @default.
- Q37427287 P2860 Q46799046 @default.
- Q37427287 P2860 Q47294166 @default.
- Q37427287 P2860 Q51376686 @default.
- Q37427287 P2860 Q51480799 @default.
- Q37427287 P2860 Q57449252 @default.
- Q37427287 P2860 Q57599459 @default.
- Q37427287 P2860 Q67317474 @default.
- Q37427287 P2860 Q78014804 @default.
- Q37427287 P2860 Q87466737 @default.